Articles by Gordon Hansen - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe
  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Gordon Hansen

Gordon Hansen


is vice-president of Analytical Sciences at Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Rd., PO Box 368, Ridgefield, CT 06877-0368, tel. 203.798.5701
Articles
Implications and Opportunities of Applying QbD Principles to Analytical Measurements
February 2, 2010
By: Mark Schweitzer , Matthias Pohl , Melissa Hanna-Brown , Phil Nethercote , Phil Borman , Gordon Hansen , Kevin Smith (Cephalon) , Jaqueline Larew

The authors present two concepts to improve robustness and facilitate continuous improvement in analytical methods. This article contain bonus online material.
Implications and Opportunities of Applying QbD Principles to Analytical Measurements
February 1, 2010
By: Mark Schweitzer , Matthias Pohl , Melissa Hanna-Brown , Phil Nethercote , Phil Borman , Gordon Hansen , Kevin Smith (Cephalon) , Jaqueline Larew

The authors present two concepts to improve robustness and facilitate continuous improvement in analytical methods.
Bringing a Science-Based Approach to Regulation: The Story of the Product Quality Research Institute
December 2, 2009
By: Gordon Hansen , Chris Allen

The authors describe the development and organization of the Product Quality Research Institute and highlight some of the important projects conducted by its Working Groups.

ADVERTISEMENT
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
18%
To all process for new products only
14%
To select process for new products only
23%
To select processes for both new and legacy products
20%
Do not use QbD
25%
View Results
Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
FindPharma Custom Search
Featured Jobs

More Jobs
Click here